Impact of the European Antimicrobial Resistance Surveillance System on the development of a national programme to monitor resistance in Staphylococcus aureus and Streptococcus pneumoniae in Ireland, 1999-2003

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 7, 2005, Pages 480-483

  Murphy, O M ^a   Murchan, S ^b   Whyte, D ^b   Humphreys, H ^c   Rossney, A ^d   Clarke, P ^c   Cunney, R ^b   Keane, C ^d   Fenelon, L E ^e   O'Flanagan, D ^b  

^a BON SECOURS HOSPITAL   (Ireland)

^b HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

^d ST JAMES S HOSPITAL   (Ireland)

^e ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; GENERAL HOSPITAL; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH SURVEY; IRELAND; LABORATORY; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IRELAND; LOGISTIC MODELS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 23744502039     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1357-z     Document Type: Article

References (15)

1. O'Brien TF (1997) The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis 24 (Suppl 1):2-8
2. The Copenhagen Recommendations (1998) Report from an Invitational European Union Conference on 'The Microbial Threat'. Copenhagen, Denmark
3. Subgroup of the Scientific Advisory Committee of the NDSC on Antimicrobial Resistance (2001) A strategy for the control of antimicrobial resistance in Ireland (SARI). The National Disease Surveillance Centre, Dublin, Ireland, pp 9-10
4. Bronzwaer SLAM, Goettsch W, Olsson-Liljequist B, Wale MC, Vatopoulos AC, Sprenger MJ (1999) European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisation. Eurosurveillance 4:41-44
5. National institute of Public Health and the Environment. EARSS Annual Report 2002. Chapter 4. Netherlands 2003. http://www.earss.rivm.nl/PAGINA/DOC/ rep2002/annual-report-2002.pdf
6. Humphreys H, O'Flanagan D (2001) Surveillance of hospital-acquired infection in the Republic of Ireland; past, present and future. J Hosp Infect 49:69-73
7. Johnson Z, Fitzpatrick P, Hayes C, Sayers G, Pelly H, McDonnell B, Thornton L, Buttimer J (1997) National survey of MRSA: Ireland, 1995. J Hosp Infect 35:175-184
8. McDonald P, Mitchell E, Johnson H, Rossney A, Humphreys H, Glynn G, Burd M, Doyle D, Mc Donnell R (2003) MRSA bacteraemia: north/south study of MRSA in Ireland 1999. J Hosp Infect 52:288-291
9. Cosgrove SE, Sakoulas G, Perencevich EN, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 53-59
10. Maugein J, Guillemot D, Dupont MJ, Fosse T, Laurans G, Roussel-Delvallez M, Thierry J, Vergnaud M, Weber M, Poirier B (2003) Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight counties. Clin Microbiol Infect 9:280-288
11. Goldsmith CE, Moore JE, Murphy PG (1997) Pneumococcal resistance in the UK. J Antimicrob Chemother 40 (Suppl A): 11-18
12. Felmingham D, Gruneberg RN and the Alexander Project Group (2000) The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community acquired lower respiratory tract infection. J Antimicrob Chemother 45:191-203
13. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, Active Bacterial Core Surveillance of the Emerging Infections Program Network (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737-1746
14. Bennett D, Lennon B, Humphreys H, Cafferkey M (2003) Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland. J Clin Microbiol 41:3641-3648
15. Clarke P, Murchan S, Smyth EG, Humphreys H (2004) Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clin Microb Infect 10: 657-659